- Conditions
- Cancer
- Interventions
- Vitamin D3, Calcium carbonate
- Dietary Supplement
- Lead sponsor
- Creighton University
- Other
- Eligibility
- 55 Years and older · Female only
- Enrollment
- 2,303 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2015
- U.S. locations
- 1
- States / cities
- Fremont, Nebraska
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1153–1176
of 33,116
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Healthy Males, Male Contraceptive
- Interventions
- First Intervention (7 days), First Washout (7 days), Second Intervention (7 days), Third Intervention (7 days), Second wash-out period
- Drug · Other
- Lead sponsor
- University of Washington
- Other
- Eligibility
- 18 Years to 50 Years · Male only
- Enrollment
- 11 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009
- U.S. locations
- 1
- States / cities
- Seattle, Washington
- Conditions
- Cocaine Dependence
- Interventions
- D-serine, Cognitive Behavioral Therapy, Placebo
- Drug · Behavioral
- Lead sponsor
- Theresa Winhusen
- Other
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2019
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
- Conditions
- PTSD, Trauma
- Interventions
- Estradiol patch, Placebo patch
- Drug · Other
- Lead sponsor
- Emory University
- Other
- Eligibility
- 18 Years to 35 Years · Female only
- Enrollment
- 127 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2025
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia
- Conditions
- Healthy Volunteers
- Interventions
- AZD2373 subcutaneous injection, Placebo
- Drug
- Lead sponsor
- AstraZeneca
- Industry
- Eligibility
- 18 Years to 55 Years · Male only
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2021
- U.S. locations
- 1
- States / cities
- Brooklyn, Maryland
- Conditions
- Severe Sepsis, Coagulopathy
- Interventions
- ART-123, Placebo
- Drug
- Lead sponsor
- Asahi Kasei Pharma America Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 816 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2019
- U.S. locations
- 22
- States / cities
- Mobile, Alabama • Phoenix, Arizona • Atlanta, Georgia + 17 more
- Conditions
- Obesity, Overweight
- Interventions
- Eloralintide, Placebo
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,980 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2030
- U.S. locations
- 41
- States / cities
- Tuscaloosa, Alabama • Scottsdale, Arizona • Escondido, California + 37 more
- Conditions
- Autistic Disorder
- Interventions
- sapropterin, Placebo
- Drug
- Lead sponsor
- The Children's Health Council
- Other
- Eligibility
- 3 Years to 6 Years
- Enrollment
- 46 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 1
- States / cities
- Palo Alto, California
- Conditions
- Hypertension
- Interventions
- Azilsartan medoxomil and chlorthalidone, Chlorthalidone
- Drug
- Lead sponsor
- Takeda
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 551 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 46
- States / cities
- Huntsville, Alabama • Montgomery, Alabama • Buena Park, California + 43 more
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Itepekimab SAR440340, Placebo
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 40 Years to 85 Years
- Enrollment
- 1,127 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2025
- U.S. locations
- 75
- States / cities
- Birmingham, Alabama • Jasper, Alabama • Chandler, Arizona + 56 more
- Conditions
- Asthma
- Interventions
- PLACEBO, MEDI528 9 mg/kg
- Other · Biological
- Lead sponsor
- MedImmune LLC
- Industry
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 11 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 4
- States / cities
- Boston, Massachusetts • St Louis, Missouri • Winston-Salem, North Carolina + 1 more
- Conditions
- Weight Loss, Other Effects of High Altitude
- Interventions
- Standard pro, High pro, carbo bev, placebo bev
- Other
- Lead sponsor
- United States Army Research Institute of Environmental Medicine
- Federal
- Eligibility
- 18 Years to 42 Years
- Enrollment
- 21 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016
- U.S. locations
- 1
- States / cities
- Natick, Massachusetts
- Conditions
- Type 1 Diabetes
- Interventions
- Liraglutide, Placebo
- Drug
- Lead sponsor
- University at Buffalo
- Other
- Eligibility
- 18 Years to 75 Years · Female only
- Enrollment
- 72 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2014
- U.S. locations
- 1
- States / cities
- Williamsville, New York
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Glucose Metabolism Disorders, Metabolic Diseases, Endocrine System Diseases
- Interventions
- Placebo, PF-04856883
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 70 Years · Female only
- Enrollment
- 84 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 7
- States / cities
- Chula Vista, California • Miami, Florida • Miramar, Florida + 4 more
- Conditions
- Chronic Kidney Diseases, Diabetes Mellitus, Diabetic Nephropathies
- Interventions
- Fisetin, Placebo oral capsule
- Dietary Supplement · Drug
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 40 Years to 80 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2027
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Hematoma, Subdural, Chronic
- Interventions
- Curcumin Pill, Placebo pills
- Drug
- Lead sponsor
- University of New Mexico
- Other
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- Albuquerque, New Mexico
- Conditions
- Parkinson Disease
- Interventions
- GOCOVRI
- Drug
- Lead sponsor
- Oregon Health and Science University
- Other
- Eligibility
- 50 Years to 80 Years
- Enrollment
- 8 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 1
- States / cities
- Portland, Oregon
- Conditions
- Arthritis, Psoriatic
- Interventions
- JNJ-88545223, Placebo
- Drug
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 240 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 18
- States / cities
- Searcy, Arkansas • Huntington Beach, California • San Diego, California + 15 more
- Conditions
- Alzheimer Disease
- Interventions
- Salsalate, Placebo
- Drug
- Lead sponsor
- Adam Boxer
- Other
- Eligibility
- 50 Years to 85 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2023
- U.S. locations
- 2
- States / cities
- San Diego, California • San Francisco, California
- Conditions
- Acne Vulgaris
- Interventions
- YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300), Placebo
- Drug
- Lead sponsor
- Bayer
- Industry
- Eligibility
- 14 Years to 45 Years · Female only
- Enrollment
- 534 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2003 – 2004
- U.S. locations
- 27
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Mesa, Arizona + 23 more
- Conditions
- Recreational Drug Use
- Interventions
- PF614, Oxycodone, Placebo
- Drug · Other
- Lead sponsor
- Ensysce Biosciences
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 27 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
- Conditions
- Plaque Psoriasis
- Interventions
- JNJ-77242113
- Drug
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 227 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 14
- States / cities
- Sacramento, California • Ocala, Florida • Tampa, Florida + 11 more
- Conditions
- Healthy
- Interventions
- Ciraparantag, Placebo, Apixaban
- Drug
- Lead sponsor
- Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.
- Industry
- Eligibility
- 50 Years to 75 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2019
- U.S. locations
- 1
- States / cities
- Secaucus, New Jersey
- Conditions
- Alcoholism, Alcohol Abuse, Alcohol Use Disorder
- Interventions
- Empower Neuromodulation System
- Device
- Lead sponsor
- Theranova, L.L.C.
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 35 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 2
- States / cities
- San Francisco, California • New Haven, Connecticut